Results 11 to 20 of about 41,202 (253)

International Guillain-Barré Syndrome Outcome Study (IGOS): protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome [PDF]

, 2017
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy with a highly variable clinical presentation, course, and outcome. The factors that determine the clinical variation of GBS are poorly understood which complicates the care and treatment of
Bateman, K., Chavada, Govindsinh, Cornblath, D. R., Cornblath, David R., Dardiotis, E., Faber, C. G., Feasby, T. E., Gorson, K. C., Gorson, Kenneth C., Harbo, T., Harbo, Thomas, Hartung, H. P., Hartung, H. P., Hartung, Hans Peter, Hughes, R. A.C., Hughes, Richard A.C., Illa, I., Islam, B., Islam, Z., Jacobs, B. C., Jacobs, B. C., Jacobs, B. C., Jacobs, Bart C., Kusunoki, S., Kusunoki, S., Kusunoki, Susumu, Lehmann, H. C., Mohammad, Q. D., Nobile-Orazio, E., Péréon, Y., Reddel, S. W., Reisin, R. C., Roodbol, J., Shahrizaila, N., van den Berg, B., van den Berg, B., van den Berg, Bianca, van den Bergh, P., van der Kooi, A. J., van Dijk, G. W., van Doorn, P. A., van Doorn, Pieter A., van Woerkom, M., Verboon, C., Verboon, C., Verboon, Christine, Visser, L. H., Wang, Y. Z., Willison, H. J., Willison, Hugh J.   +49 more
core   +22 more sources

Guillain–Barre Syndrome [PDF]

Seminars in Neurology, 2019
AbstractGuillain–Barre syndrome (GBS) is the leading cause of acute paralysis that can potentially affect all of the human population. GBS is believed to be an immune-mediated disease, possibly triggered by a recent infection, and driven by an immune attack targeting the peripheral nervous system.
Elia Malek, Johnny Salameh
  +9 more sources

Guillain-Barre Syndrome Following Ad26.Cov2.S Covid-19 Vaccine: A Case Report

Journal of Nobel Medical College, 2021
Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the ...
Sushmita Khanal, Sunil Babu Khanal
doaj   +1 more source

Second intravenous immunoglobulin dose in patients with Guillain-Barre syndrome with poor prognosis (SID-GBS):a double-blind, randomised, placebo-controlled trial [PDF]

, 2021
Background Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is insufficient in a proportion of patients with severe Guillain-Barre syndrome.
, Arends, Samuel, Badrising, Umesh A., Bienfait, Henriette M. E., Blom, Roderik J., Breukelman, Albert-Jan J., Budde, Ilona Kleine, de Rijk, Maarten C., Dieks, Rita J. G., Doets, Alexandra Y., Drenthen, Judith, Eftimov, Filip, Faber, Catharina G., Garssen, Marcel P. J., Gijsbers, Cees J., Gilhuis, H. Job, Groen, Rutger J., Huizinga, Ruth, Jacobs, Bart C., Jellema, Korne, Kleyweg, Ruud P., Kuitwaard, Krista, Kuks, Jan B. M., Leonhard, Sonja E., Lingsma, Hester F., Linssen, Wim H. J. P., Lovenich, Harry, Merkies, Ingemar S. J., Samijn, Johnny P. A., Stevens, Martijn, Steyerberg, Ewout W., van den Berg, Bianca, van der Graaff, Maaike M., van der Kooi, Anneke J., van der Kooi, Elly L., van der Meulen, Marjon F. G., van der Meulen, Willem D. M., van der Pol, W. Ludo, van der Ree, Taco C., van Dijk, Gert W., van Engelen, Baziel G. M., van Koningsveld, Rinske, van Oosten, Bob W., Verboon, Christine, Vermeij, Frederique H., Verschuuren, Jan J. G. M., Visser, Leo H., Walgaard, Christa, Wirtz, Paul W., Wohlgemuth, Marielle, Zwetsloot, Casper P.   +50 more
core   +1 more source

Guillain–Barre syndrome after myocardial infarction: a case report and literature review

BMC Cardiovascular Disorders, 2023
Background Guillain–Barre syndrome after myocardial infarction occurs infrequently, and its occurrence following percutaneous coronary intervention is extremely rare.
Pu-yuan Wen, Xian-wen Chen, Min Zhang, Wen-zheng Chu, Hong-liang Wu, Chao Ren   +5 more
doaj   +1 more source

Specificity of recovery in acute motor axonal neuropathy with conduction blocks on the example of two clinical cases

Нервно-мышечные болезни, 2020
Introduction. The heterogeneity of the forms and severity of Guillain-Barre syndrome explains the variability of recovery: from rapid and complete (in most cases) to slow with the development of persistent residual deficiency (rarely).
D. A. Grishina, N. A. Suponeva
doaj   +1 more source

Guillain-Barre Syndrome, Clinical Spectrum and Electrophysiological Sub Types: A Local Experience

Journal of Shalamar Medical & Dental College, 2023
Background: Guillain-Barre syndrome is uncommon neurological disease that occurs in acute phase as generalized polyradiculo-neuropathy. It has multiple variants some of them being uncommon and rarely encountered.
Faryal Shamim, Safia bano safia, Masooma Waqar, Ahsan Numan   +3 more
doaj   +1 more source

New technologies in rehabilitation: plantar imitator of bearing load for patients with Guillain-Barre syndrome

Анналы клинической и экспериментальной неврологии, 2017
Guillain-Barre syndrome often requires administration in intensivecare unit but is associated with good prognosis. That usuallymeans partial or full regress of motor impairment. However,we found that many reconvalescents after Guillain-Barre syndromewere
A. A. Khoroshun, M. A. Piradov, L. A. Chernikova   +2 more
doaj   +1 more source

Guillain-Barre syndrome in pregnancy: A rare disease with challenging management

Ibom Medical Journal, 2023
Background: Guillain-Barre syndrome is a rare autoimmune disorder in pregnancy, characterised by ascending polyneuropathy. Diagnosis is mainly clinical and treatment is mainly supportive.
Uwagboe UC, Isikhuemen ME
doaj   +1 more source

Neurosyphilis presenting with Guillain–Barre syndrome: a case report

BMC Neurology, 2023
Background Syphilis is associated with a wide variety of systemic presentations, earning it the moniker “The great mimicker”. Neurosyphilis is classically associated with meningovasculitis in the acute-subacute stage and tabes dorsalis and dementia ...
Hoameng Ung, Dominic Ferrey
doaj   +1 more source